Abstract |
The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturation mutagenesis and DNA shuffling to screen precise gene-variant yeast display libraries for improved PfCSP antigen recognition. We identified several mutations that improved recognition, predominately in framework regions, and combined these to produce a panel of antibody variants. The most improved antibody, CIS43_Var10, had three mutations and showed approximately sixfold enhanced protective potency in vivo compared to CIS43. Co-crystal and cryo-electron microscopy structures of CIS43_Var10 with the peptide epitope or with PfCSP, respectively, revealed functional roles for each of these mutations. The unbiased site-directed mutagenesis and screening pipeline described here represent a powerful approach to enhance protective potency and to enable broader clinical use of antimalarial antibodies.
|
Authors | Bailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, Jason Gorman, Thuy Duong Nguyen, Marlon Dillon, Ahmed S Fahad, Patience K Kiyuka, Bharat Madan, Jacy R Wolfe, Brian Bonilla, Barbara Flynn, Joseph R Francica, Nicholas K Hurlburt, Neville K Kisalu, Tracy Liu, Li Ou, Reda Rawi, Arne Schön, Chen-Hsiang Shen, I-Ting Teng, Baoshan Zhang, Marie Pancera, Azza H Idris, Robert A Seder, Peter D Kwong, Brandon J DeKosky |
Journal | The Journal of experimental medicine
(J Exp Med)
Vol. 219
Issue 8
(08 01 2022)
ISSN: 1540-9538 [Electronic] United States |
PMID | 35736810
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 Banach et al. |
Chemical References |
- Antibodies, Protozoan
- Antimalarials
- Malaria Vaccines
- Protozoan Proteins
|
Topics |
- Antibodies, Protozoan
- Antimalarials
(pharmacology)
- Cryoelectron Microscopy
- Humans
- Malaria Vaccines
- Plasmodium falciparum
- Protozoan Proteins
- Saccharomyces cerevisiae
(genetics)
|